B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Entospletinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Entospletinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

repotrectinib
3 shared targets
entrectinib
5 shared targets
pralsetinib
2 shared targets
selitrectinib
2 shared targets
lorlatinib
3 shared targets
bdb
2 shared targets
spebrutinib
2 shared targets
ceritinib
6 shared targets
sulfuretin
3 shared targets
glesatinib
3 shared targets
Loading evidence profile...

This evidence profile for Entospletinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.